CRL · Charles River Laboratories International, Inc.
Market Cap
$13.93B
Shares
47.74M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$4.02B
-0.9%
FY2025
Net Income
-$144.34M
-750.1%
FY2025
Gross Margin
84.41%
+0.9pp
FY2017
Operating Margin
0.63%
-5pp
FY2025
Diluted EPS
-$2.91
-1555%
FY2025
Operating Cash Flow
$737.65M
+0.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $4B | $4.02B | $4.05B | $4.13B | $3.98B | $3.54B | $2.92B | $2.62B | $2.27B | $1.86B | $1.68B | $1.36B | $1.3B | $1.17B | $1.13B | $1.14B | $1.13B | $1.17B | $1.3B | |
| — | — | — | — | — | — | — | — | — | $289.67M | $277.03M | $263.98M | $266.42M | $272.75M | $257.71M | $267.97M | $252.96M | $255.68M | $252.94M | |
| — | — | — | — | — | — | — | — | — | $1.57B | $1.4B | $1.1B | $1.03B | $892.78M | $871.82M | $874.68M | $880.45M | $915.96M | $1.04B | |
| — | — | — | — | — | — | — | — | — | 84.41% | 83.52% | 80.64% | 79.47% | 76.6% | 77.18% | 76.55% | 77.68% | 78.18% | 80.47% | |
| $762.04M | $743.07M | $751M | $747.86M | $665.1M | $619.92M | $528.94M | $517.62M | $443.85M | $371.27M | $364.71M | $300.41M | $269.03M | $225.7M | $208.25M | $198.65M | $232.49M | $227.66M | $223.94M | |
| $78.35M | $179.07M | $138.47M | $137.44M | $146.58M | $124.86M | $111.88M | $89.54M | $64.83M | $41.37M | $41.7M | $24.23M | $25.96M | $17.81M | $18.07M | $21.8M | $24.41M | $25.72M | $26.73M | |
| $297.88M | $403.31M | $361.74M | $314.12M | $303.87M | $265.54M | $234.92M | $198.1M | $161.78M | $131.16M | $126.66M | $94.88M | $96.45M | $96.64M | $81.28M | $85.23M | $93.65M | $89.96M | $86.85M | |
| $98.41M | $99.81M | $106.99M | $29.68M | $8.21M | $6.86M | $12.59M | $13.84M | $9.55M | $4.78M | $17.88M | $8.01M | $7.79M | $3.22M | $2.58M | $5.46M | — | — | — | |
| $90.14M | $25.16M | $227.35M | $617.26M | $650.98M | $589.86M | $432.73M | $351.15M | $331.38M | $288.28M | $237.55M | $206.45M | $177.67M | $151.4M | $165.77M | $174.31M | -$298.51M | $169.61M | -$451.84M | |
| — | 0.63% | 5.61% | 14.95% | 16.37% | 16.66% | 14.8% | 13.4% | 14.62% | 15.52% | 14.13% | 15.14% | 13.69% | 12.99% | 14.68% | 15.25% | -26.34% | 14.48% | -34.88% | |
| $388.03M | $428.47M | $589.09M | $931.39M | $954.85M | $855.4M | $667.65M | $549.25M | $493.16M | $419.44M | $364.21M | $301.33M | $274.12M | $248.04M | $247.04M | $259.54M | -$204.86M | $259.58M | -$364.99M | |
| $106.26M | $107.03M | $126.29M | $136.71M | $59.29M | $73.91M | $86.43M | $60.88M | $63.77M | $29.78M | $27.71M | $15.07M | $11.95M | $20.97M | $33.34M | $42.59M | $35.28M | $21.68M | $22.34M | |
| $4.5M | $4.94M | $8.58M | $5.2M | $780K | $652K | $834K | $1.52M | $812K | $690K | $1.31M | $1.04M | $1.15M | $730K | $589K | $1.35M | $1.19M | $1.71M | $7.88M | |
| -$172.06M | -$22.58M | -$16.52M | $95.54M | $30.52M | -$35.89M | $99.98M | $12.29M | $13.26M | $37.76M | $11.76M | $3.01M | $10.72M | $7.17M | -$3.27M | -$411K | -$1.48M | $1.91M | -$5.15M | |
| $8.74M | — | — | — | — | — | — | — | — | — | — | $3.82M | $9.3M | $5.86M | -$618K | — | — | — | — | |
| — | -$99.5M | $93.11M | $581.28M | $622.99M | $480.71M | $447.11M | $304.08M | $281.68M | $296.96M | $222.92M | $195.43M | $177.6M | $138.33M | $129.75M | $132.66M | -$334.08M | $151.56M | -$471.45M | |
| $52.63M | $42.66M | $67.82M | $100.91M | $130.38M | $81.87M | $81.81M | $50.02M | $54.46M | $171.37M | $66.84M | $43.39M | $47.67M | $32.91M | $27.63M | $17.14M | $23K | $40.35M | $57.03M | |
| -$238.46M | -$144.34M | $22.2M | $474.62M | $486.23M | $390.98M | $364.3M | $252.02M | $226.37M | $123.36M | $154.77M | $149.31M | $126.7M | $102.83M | $97.87M | $109.98M | -$336.67M | $114.44M | -$524.51M | |
| — | -3.59% | 0.55% | 11.49% | 12.23% | 11.04% | 12.46% | 9.61% | 9.99% | 6.64% | 9.2% | 10.95% | 9.76% | 8.82% | 8.66% | 9.62% | -29.7% | 9.77% | -40.49% | |
| $2.16M | $2.18M | $3.09M | $5.75M | $6.38M | $7.86M | $1M | $2.04M | $2.35M | $2.09M | $1.6M | $1.77M | $1.5M | $1.32M | $571K | $411K | -$5.45M | -$1.84M | -$687K | |
| — | -$144.34M | $10.3M | $474.62M | $486.23M | — | — | — | — | — | — | $149.31M | $126.7M | $102.83M | $97.3M | $109.57M | -$336.67M | $114.44M | — | |
| -$267.98M | $1.22M | -$98.72M | $540.25M | $388.91M | $365.12M | $403.45M | $246.7M | $201.73M | $232.39M | $36.55M | $88.01M | $47.09M | $101.58M | $99.31M | $80.52M | -$348.07M | — | — | |
| USD/shares | -$4.80 | -$2.91 | $0.20 | $9.27 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | $2.15 | $2.03 | $2.16 | -$5.38 | $1.75 | -$7.80 |
| USD/shares | -$4.80 | -$2.91 | $0.20 | $9.22 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | $2.12 | $2.01 | $2.14 | -$5.38 | $1.74 | -$7.80 |
| shares | — | 49.56M | 51.38M | 51.23M | 50.81M | 50.29M | 49.55M | 48.73M | 47.95M | 47.48M | 47.01M | 46.5M | 46.63M | 47.74M | 47.91M | 50.82M | 62.56M | 65.37M | — |
| shares | — | 49.56M | 51.63M | 51.45M | 51.3M | 51.43M | 50.61M | 49.69M | 49.02M | 48.56M | 47.96M | 47.63M | 47.56M | 48.49M | 48.41M | 51.32M | 62.56M | 65.64M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $2.03B in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 37 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 6.06×
EV/EBIT
—
Peer median 60.68×
P/E (TTM)
—
Peer median 32.77×
Peer medians compare against the 24 similar-size Diagnostics & Research companies (of 46 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Discovery and Safety Assessment Segment | $2,402,891,000 | $2,451,280,000 | — | — | — | — | — | — |
| Research Models and Services Segment | $846,082,000 | $829,377,000 | $792,343,000 | $739,175,000 | — | — | — | — |
| Manufacturing Support Segment | $766,409,000 | $769,332,000 | $721,443,000 | $789,569,000 | — | — | — | — |
| Discovery and Safety Assessment | — | — | $2,615,623,000 | $2,447,316,000 | $2,107,231,000 | $1,837,428,000 | $1,618,995,000 | $1,316,854,000 |
| Manufacturing Support | — | — | — | — | $742,492,000 | $515,353,000 | $465,142,000 | $429,560,000 |
| Research Models and Services | — | $829,377,000 | — | — | $690,437,000 | $571,152,000 | $537,089,000 | $519,682,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $2,141,773,000 | $2,239,977,000 | $2,347,486,000 | $2,342,158,000 | $1,934,404,000 | $1,627,149,000 | $1,471,097,000 | $1,267,620,000 |
| Europe | $1,102,696,000 | $1,078,146,000 | $1,076,937,000 | $1,032,125,000 | $1,036,465,000 | $829,312,000 | $726,421,000 | $643,957,000 |
| Canada | $501,025,000 | $482,093,000 | $487,305,000 | $398,982,000 | $339,098,000 | $306,259,000 | $271,987,000 | $206,382,000 |
| Asia Pacific | $205,023,000 | $196,952,000 | $200,833,000 | $192,837,000 | $222,902,000 | $155,086,000 | $146,218,000 | — |
| Other | $64,865,000 | $52,821,000 | $16,848,000 | $9,958,000 | $7,291,000 | $6,127,000 | $5,503,000 | $5,642,000 |
| Japan | — | — | — | — | — | — | — | $142,495,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Service | $3,250,099,000 | $3,304,138,000 | $3,440,019,000 | $3,216,904,000 | $2,755,579,000 | $2,296,156,000 | $2,029,371,000 | $1,687,941,000 |
| Product | $765,283,000 | $745,851,000 | $689,390,000 | $759,156,000 | $784,581,000 | $627,777,000 | $591,855,000 | $578,155,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Discovery and Safety Assessment Segment | $424,555,000 | $442,510,000 | $606,076,000 | $532,889,000 | — | — | — | — |
| Reportable Segment Aggregation Before Other Operating Segment | $284,838,000 | $485,468,000 | $849,071,000 | $860,383,000 | — | — | — | — |
| Research Models and Services Segment | $44,567,000 | $114,411,000 | $154,666,000 | $160,410,000 | — | — | — | — |
| Manufacturing Support Segment | -$184,284,000 | -$71,453,000 | $88,329,000 | $167,084,000 | — | — | — | — |
| Discovery and Safety Assessment | — | — | $606,076,000 | $532,889,000 | $406,978,000 | $325,959,000 | $258,903,000 | $227,577,000 |
| Manufacturing Support | — | — | $88,329,000 | $167,084,000 | $246,390,000 | $181,494,000 | $145,420,000 | $136,212,000 |
| Research Models and Services | — | — | $154,666,000 | $160,410,000 | $166,814,000 | $102,706,000 | $133,912,000 | $136,468,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Discovery and Safety Assessment Segment | 17.7% | 18.1% | — | — | — | — | — | — |
| Research Models and Services Segment | 5.3% | 13.8% | 19.5% | 21.7% | — | — | — | — |
| Manufacturing Support Segment | -24% | -9.3% | 12.2% | 21.2% | — | — | — | — |
| Discovery and Safety Assessment | — | — | 23.2% | 21.8% | 19.3% | 17.7% | 16% | 17.3% |
| Manufacturing Support | — | — | — | — | 33.2% | 35.2% | 31.3% | 31.7% |
| Research Models and Services | — | — | — | — | 24.2% | 18% | 24.9% | 26.3% |
Key facts
CIK
1100682
CUSIP
159864107
13F (30d)
397 filings
391 filers
Visit website
Investor relations